Testing TA-65 for blood vessel function in heart disease
Part of Heart & circulation clinical trials.
This study tests TA-65 to see if it improves how well small blood vessels work, which can be worse with aging and coronary artery disease (CAD). You may be eligible if you’re in the right age group and meet the heart-diagnosis and health-stability requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are either age 18–35 or age 65+
- You have a clinical diagnosis of coronary artery disease (CAD)
- If you’re age 36–64, you must have CAD (otherwise you’re not eligible)
- You have not had a heart attack or stroke (a major event) in the past year
- You do not have heart failure or kidney problems
- You do not have uncontrolled blood pressure, diabetes, or current/very recent smoking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
This study looks at how exercise changes blood vessels differently in older women and men. You'll be randomly assigned to either an exercise program or a no-exercise control group for a few months, and researchers will measure your blood vessel health before and after.
This early-phase study tests how angiotensin-(1-7) affects blood vessels and the heart in people ages 65–80. It may help researchers understand how to improve cardiovascular function as we age.
This trial tests whether spa treatments using ultrasound can help older adults stay healthy and active. You may be able to join if you are 70 or older and can do daily activities like climbing stairs or getting in and out of a bath.
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
This study tests if TB-500 can improve blood markers of cardiovascular health in people with stable artery disease. It is an early-phase trial to see if the drug is safe and shows promise.
Hear when a new Vascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.